期刊文献+

冠脉支架植入对冠心病患者血清IL-18及CRP水平的影响 被引量:1

Effects of intracoronary stent on serum IL-18 and CRP levels of patients with coronary heart disease
下载PDF
导出
摘要 目的:观察冠心病患者冠脉支架植入前后,血清白细胞介素18(IL-18)及C反应蛋白(CRP)水平的变化。方法:冠心病患者30例在冠脉支架植入前后,分别于空腹12 h后清晨采集静脉血5 ml。采用双抗体夹心ELISA法测定外周血清IL-18的浓度,选用全自动生化分析仪测定CRP的含量,并比较冠脉支架植入术前后IL-18和CRP水平的变化。结果:冠脉支架植入术前,血清IL-18的平均浓度为(1.42±0.47)ng/L,术后平均浓度为(2.64±0.54)ng/L,两者比较差异具有显著性(P<0.01)。术前血清CRP的平均浓度为(5.26±1.28)mg/L,术后平均浓度为(11.86±1.61)mg/L,两者比较差异也具有显著性(P<0.01)。结论:冠脉支架植入术对血清IL-18及CRP的水平有明显影响。 AIM: To observe the changes of the levels of interleukin-18 (IL-18) and C-reactive protein (CRP) before and after intracoronary stent in patients with coronary heart disease (CHD). METHODS: Five ml blood was collected during the early morning from peripheral vein before and after intracoronary stent treatment in 30 CHD patients. IL-18 was detected with ELISA, and CRP was measured with an automatic biochemical analyzer. RESULTS: The concentration of IL-18 was significantly elevated after intracoronary stent [(2.64±0.54)ng/L vs. (1.42±0.47)ng/L, P〈0.01]. The concentration of CRP was also significantly elevated after intracoronary stent [(11.86±1.61) mg/L vs. (5.26±1.28) mg/L, P〈0.01]. CONCLUSION: Concentrations of IL-18 and CRP in CHD patients are significantly elevated after intracoronary stent.
出处 《心脏杂志》 CAS 2009年第6期832-833,837,共3页 Chinese Heart Journal
关键词 冠状动脉疾病 白细胞介素18 C反应蛋白 冠脉支架植入术 coronary heart disease interleukin-18 C-reactive protein intracoronary stent
  • 相关文献

参考文献6

二级参考文献24

  • 1许官学,石蓓,赵然尊,刘志江,郭艳,陶明,余国珍.急性冠脉综合征介入治疗前后C-反应蛋白的变化及临床意义[J].医师进修杂志,2005,28(1):40-41. 被引量:9
  • 2谢千,曾建新,黄干洪,徐志奇,毕建成.急性冠脉综合征介入治疗前后血清CRP变化观察[J].现代医院,2006,6(3):40-41. 被引量:2
  • 3[1]Maseri A,Liuzzo G,Biasucci LM.Pathogenic mech-anisms in unstable angina.Heart,1999,82:12-14.
  • 4[2]WeltF GP,Edelman ER,Simon DI,et al.Neutrophil,not macrophage,infiltration precedes neointimal thickening in balloon-injured arteries.Arterioscler Thromb Vasc Biol,2000,20:2553-2558.
  • 5[3]Ziad M,Anne C,Alexandra S,et al.Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability.Circulation,2001,104:1598-1601.
  • 6[4]CDC/AHA Workshop on marders of inflammation and cardiovascular disease:application to clinical and public health practice:clinical use of inflammatory markers in patients with cardiovascular diseases:a background paper.Circulation,2004,110:560-567.
  • 7[5]Hoshida S,Nishino M,Banai S,et al.A persistent increase in Creactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins.Atherosclerosis 2004,173:285-290.
  • 8Ross, R. Atheroclerosis in inflammatory disease. N Engl J Med, 1999,340(2):115 - 126.?A
  • 9Maseri A. Inflammation, atherosclerosis and ischemic events - exploring the hidden side of the moon. N Engl J Med, 1997,336(14):1 014-1 016.?A
  • 10Edward TH, Y eh MD, Hvemon Anderson MD, et al. C- Reactive protein linking inflammation to cardiovascular complications. Circulation, 2001,104:974 - 975.?A

共引文献10

同被引文献17

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部